Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Cost of RevenueEBIATGross ProfitLeasesLong-Term Debt RepaymentsNon-Current ReceivablesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsReceivables - NetReceivables - OtherReceivables RefundsShares OutstandingShares OutstandingShort-Term Debt issuancesShort-Term Debt repayments
Ratios

Zepp Health (ZEPP) Accumulated Depreciation & Amortization (2016 - 2023)

Zepp Health has reported Accumulated Depreciation & Amortization over the past 8 years, most recently at -$8.8 billion for Q4 2023.

  • For Q4 2023, Accumulated Depreciation & Amortization fell 60949.14% year-over-year to -$8.8 billion; the TTM value through Dec 2023 reached -$8.8 billion, down 60949.14%, while the annual FY2023 figure was -$8.8 billion, 60949.14% down from the prior year.
  • Accumulated Depreciation & Amortization for Q4 2023 was -$8.8 billion at Zepp Health, down from $14.4 million in the prior quarter.
  • Over five years, Accumulated Depreciation & Amortization peaked at $14.4 million in Q4 2022 and troughed at -$8.8 billion in Q4 2023.
  • A 5-year average of -$1.7 billion and a median of $5.2 million in 2020 define the central range for Accumulated Depreciation & Amortization.
  • Biggest five-year swings in Accumulated Depreciation & Amortization: skyrocketed 325.22% in 2019 and later plummeted 60949.14% in 2023.
  • Year by year, Accumulated Depreciation & Amortization stood at $2.6 million in 2019, then surged by 101.97% to $5.2 million in 2020, then surged by 86.3% to $9.6 million in 2021, then skyrocketed by 49.92% to $14.4 million in 2022, then plummeted by 60949.14% to -$8.8 billion in 2023.
  • Business Quant data shows Accumulated Depreciation & Amortization for ZEPP at -$8.8 billion in Q4 2023, $14.4 million in Q4 2022, and $9.6 million in Q4 2021.